Dr. Michael M. Amiri, MD

Dr. Amiri practices at Mecklenburg Neurology Group in Concord, North Carolina.

Dr. Amiri's NPI, 1720161011, was assigned on October 23, 2006. Dr. Amiri holds North Carolina license 109177.

Dr. Amiri's primary practice is Mecklenburg Neurology Group, at 70 Lake Concord NE Rd, Concord, NC 28025 in Cabarrus County. The practice phone is (980) 777-8311.

Dr. Amiri's primary practice is Mecklenburg Neurology Group in Concord, North Carolina. Dr. Amiri is also affiliated with Novant Health Presbyterian Medical Center. The medical group on file is Mecklenburg Neurology Group. Dmand AI also links Dr. Amiri to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amiri practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Amiri's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Amiri is licensed in North Carolina.

CMS data shows 1,593 Medicare services from Dr. Amiri across 15 procedure codes in 2024, for 502 Medicare patients. Medicare paid $186,368 for them.

CMS counts 502 Medicare patients who saw Dr. Amiri in 2024. The largest group is 75 to 84, with 174 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amiri's median patient age at 56, with 61% women.

In 2024, Dr. Amiri wrote 5,873 Medicare Part D claims for 998 patients. 86% of them were for generic drugs. CMS names the drug for 5,574 of them, across 72 drugs with 11 or more claims each, at $1,222,984 in total drug cost. In 2023, CMS named 2,972 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Amiri for performance year 2024, reported individually. Dr. Amiri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amiri as offering telehealth.

Dmand AI links Dr. Amiri to 1 clinical trial. Conditions studied include Epilepsy and Brain Diseases.

CMS Open Payments shows 2,621 general payments to Dr. Amiri from 103 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Sunovion Pharmaceuticals Inc. paid the most, $15,103.